Condition: AV Block Complete · Tricuspid Regurgitation (TR) · Sponsor: Deutsches Herzzentrum Muenchen
Transcatheter tricuspid valve replacement (TTVR) is associated with a high risk of third-degree atrioventricular block (AVB). However, the optimal pacemaker management following TTVR remains unclear. This study aims to identify an optimal therapeutic approach for pacemaker implantation in patients undergoing TTVR.
This description comes directly from the study's public registry record.
Carsten Lennerz, PD Dr. med. · 0049 89 1218 4401 · lennerz@dhm.mhn.de
Always discuss trial participation with your own doctor first.
| Deutsches Herzzentrum München | München, Bavaria, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06814574